liveBook · Manning

DNABERT

As explained in Build AI Drug Discovery Pipelines

DNABERT is a transformer model trained on DNA sequences to learn patterns associated with gene regulation and sequence function.

DNABERT is a transformer model trained on DNA sequences. It uses BERT-style masked language modeling on large genomic sequence collections to learn statistical patterns associated with gene regulation, transcription factor binding, and sequence function. section 13.2.1

In drug discovery, genomic modeling can support target identification and validation. DNABERT applications include predicting the effects of non-coding variants on gene regulation, identifying regulatory elements such as enhancers and silencers, and designing gene therapy vectors for optimized expression. section 13.2.1

DNABERT is trained on DNA, not RNA. For RNA-focused tasks, generally use a model trained or fine-tuned on RNA instead. section 13.2.1

How Build AI Drug Discovery Pipelines covers it

How deep it goes
Summarizes training and applications without implementation steps or evaluation results.
Examples
Names non-coding variant effects, regulatory element identification, and gene therapy vector design as applications.
What you can do after
Understand where DNABERT can support genomic analysis and why RNA tasks generally require a different model.
How it connects
Connects DNA sequence modeling to gene regulation, transcription factor binding, and protein sequence modeling with ESM-2.

This explainer was generated by Manning's knowledge graph from the text of Build AI Drug Discovery Pipelines. The section links point to the parts of the book it draws on.